









Markets
/
Stocks
/
nasdaq-cdt
/

Conduit Pharmaceuticals Inc

CDT

1.590USD

+0.010+0.63%

Close 12/24, 13:00（ET）Quotes delayed by 15 min

2.03MMarket Cap

LossP/E TTM



Conduit Pharmaceuticals Inc

1.590

+0.010+0.63%

Overview Company Financials Analysis

Overview

Company

Financials

Analysis

Cash Flow Statement

You can access the annual and quarterly cash flow statements of Conduit Pharmaceuticals Inc to evaluate its financial soundness and stability.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

Operating cash flows (indirect method)

Cash flow from continuing operating activities

-120.61%-4.41M

-44.08%-2.18M

-83.67%-4.33M

20.61%-3.81M

-281.49%-2.00M

-252.68%-1.51M

-19.71%-2.36M

-445.80%-4.80M

-15.93%-524.00K

-193.84%-429.00K

-149.87%-1.97M

---880.00K

---452.00K

---146.00K

---788.00K

Net income from continuing operations

-10.17%-7.12M

-4.68%-5.63M

-44.88%-5.15M

-235.24%-2.41M

-373.89%-6.46M

-114.63%-5.38M

-64.06%-3.55M

157.93%1.78M

346.76%2.36M

-353.53%-2.51M

-605.21%-2.17M

---3.07M

---956.00K

---553.00K

---307.00K

Operating gains losses

17600.00%885.00K

--835.00K

--190.00K

--452.00K

--5.00K

----

Other non-cash items

-81.18%397.00K

-151.77%-1.44M

73.15%1.57M

93.44%-153.00K

202.08%2.11M

--2.79M

272.43%905.00K

-620.54%-2.33M

---2.07M

----

--243.00K

--448.00K

----

Change in working capital

-118.35%-342.00K

60.49%979.00K

-502.49%-1.21M

42.76%-2.42M

198.72%1.86M

-48.39%610.00K

-2.55%-201.00K

-950.60%-4.22M

30.82%624.00K

885.00%1.18M

60.56%-196.00K

--496.00K

--477.00K

--120.00K

---497.00K

-Change in prepaid expenses

-467.71%-353.00K

396.08%453.00K

-66.67%-255.00K

-90.49%-2.06M

--96.00K

---153.00K

---1.08M

----

-Change in other current assets

----

--5.00K

----

--0.00

---5.00K

----

-Change in other current liabilities

--653.00K

244.90%71.00K

-522.45%-207.00K

158.99%1.03M

----

---49.00K

--49.00K

---1.75M

----

Cash from non-recurring investing activities

Cash from operating activities

-120.61%-4.41M

-44.08%-2.18M

-83.67%-4.33M

20.61%-3.81M

-281.49%-2.00M

-252.68%-1.51M

-19.71%-2.36M

-445.80%-4.80M

-15.93%-524.00K

-193.84%-429.00K

-149.87%-1.97M

---880.00K

---452.00K

---146.00K

---788.00K

Investing cash flow

Net cash from continuing investing activities

2339.02%1.00M

--401.00K

--4.00K

--0.00

--41.00K

----

Capital expenditures

2339.02%1.00M

--401.00K

--4.00K

--0.00

--41.00K

----

Net cash flow from disposal of fixed assets

2339.02%1.00M

--401.00K

--4.00K

--0.00

--41.00K

----

Net cash flow from investment products

-103.65%-5.00K

----

--85.00K

--137.00K

----

Net cash flow from other investing activities

--7.00K

----

100.00%0.00

1020.37%497.00K

534.11%560.00K

---89.00K

---243.00K

---54.00K

---129.00K

----

Cash from non-current investing activities

Net cash flow from investing activities

-1139.58%-998.00K

-79.02%-401.00K

---4.00K

-82.90%85.00K

-82.86%96.00K

-151.69%-224.00K

100.00%0.00

1020.37%497.00K

534.11%560.00K

---89.00K

---243.00K

---54.00K

---129.00K

----

Financing cash flow

Cash flow from continuous financing activities

243.86%6.00M

3224.78%3.76M

--5.93M

1116.91%4.21M

-79.77%1.74M

-77.58%113.00K

-100.00%0.00

-144.37%-414.00K

1493.16%8.62M

172.43%504.00K

181.37%2.22M

--933.00K

--541.00K

--185.00K

--789.00K

Net cash flow from debt Issuance/repayment

-109.32%-11.00K

---24.00K

---2.13M

46540.00%2.33M

-82.95%118.00K

----

-100.00%0.00

-98.82%5.00K

79.27%692.00K

-82.05%21.00K

--2.22M

--425.00K

--386.00K

--117.00K

----

Net cash flow from common stock issuance/repurchase

269.72%6.01M

--3.78M

--8.06M

441.97%1.70M

226.31%1.63M

----

-197.46%-498.00K

221.29%498.00K

610.29%483.00K

----

--511.00K

--155.00K

--68.00K

--789.00K

Proceeds from issuance of warrants

----

--175.00K

--1.00K

----

Net cash flow from other financing activities

----

2733.33%79.00K

--7.43M

----

---3.00K

----

Net cash from non-recurrent financing activities

Net cash from financing activities

243.86%6.00M

3224.78%3.76M

--5.93M

1116.91%4.21M

-79.77%1.74M

-77.58%113.00K

-100.00%0.00

-144.37%-414.00K

1493.16%8.62M

172.43%504.00K

181.37%2.22M

--933.00K

--541.00K

--185.00K

--789.00K

Net cash flow

Beginning cash balance

1421.46%3.33M

15.51%2.13M

-86.90%554.00K

-99.18%71.00K

--219.00K

22950.00%1.84M

--4.23M

--8.64M

-100.00%0.00

300.00%8.00K

--0.00

--39.00K

--2.00K

--0.00

Current period cash flow changes

441.89%506.00K

173.97%1.20M

166.11%1.58M

110.94%483.00K

-101.71%-148.00K

-20212.50%-1.63M

-29900.00%-2.38M

---4.42M

22264.10%8.64M

-121.62%-8.00K

300.00%8.00K

--0.00

---39.00K

--37.00K

--2.00K

Effect of exchange rate changes

-854.55%-83.00K

2700.00%26.00K

33.33%-18.00K

-99.67%1.00K

200.00%11.00K

-116.67%-1.00K

---27.00K

30300.00%304.00K

-1200.00%-11.00K

400.00%6.00K

----

--1.00K

---2.00K

--1.00K

Ending cash balance

5305.63%3.84M

1421.46%3.33M

15.51%2.13M

-86.90%554.00K

-99.18%71.00K

--219.00K

22950.00%1.84M

--4.23M

--8.64M

-100.00%0.00

300.00%8.00K

--0.00

--39.00K

--2.00K

Free cash flow

-165.20%-5.41M

---2.58M

-83.84%-4.33M

20.61%-3.81M

-289.31%-2.04M

----

-19.71%-2.36M

-445.80%-4.80M

-15.93%-524.00K

---429.00K

---1.97M

---880.00K

---452.00K

----

Currency unit

USD

Audit opinions

FAQs

What is the cash flow statement?



This report tracks the movement of cash into and out of the business, covering operating, investing, and financing activities. It highlights how well the company manages cash to support growth and meet its obligations.

KeyAI

